Trials / Completed
CompletedNCT02028533
Cocaine Opioid Oxytocin Option - Limited
Chronic Intranasal Oxytocin as an Adjunct to Methadone Maintenance Treatment in Patients With Co-occuring Opioid Use Disorder and Cocaine Use: A 2-week Pilot Study
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- University of California, San Francisco · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a pilot feasibility study assessing the tolerability of chronic administration of intranasal oxytocin to patients receiving methadone at an opioid replacement clinic who are actively using cocaine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Oxytocin | |
| DRUG | Placebo |
Timeline
- Start date
- 2014-07-01
- Primary completion
- 2014-12-01
- Completion
- 2014-12-01
- First posted
- 2014-01-07
- Last updated
- 2019-05-21
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02028533. Inclusion in this directory is not an endorsement.